Company Profile
Alchemia was a biopharmaceutical company focused on the discovery and development of innovative drugs based on its proprietary HyACT® drug delivery platform, which enhances the efficacy of chemotherapeutics.
HyACT® technology improves the delivery of anti-cancer drugs targeting them more precisely to tumor sites, reducing side effects and increasing efficacy. The company’s lead product candidate, HA-Irinotecan, demonstrated promising results in colorectal cancer treatment.
